Cornerstone BioPharma has acquired the rights to a variety of drugs for the treatment of respiratory problems and allergies from Fleming & Company Pharmaceuticals.

Terms were not disclosed.

The drugs come in pills, chewable and syrup forms and are known as Extendryl.

Cornerstone will manufacture and market the drugs.

The company was launched in 2004.